Close
New

Medscape is available in 5 Language Editions – Choose your Edition here.

 

Arterial Vascular Malformations Including Hemangiomas and Lymphangiomas Workup

  • Author: Robert A Schwartz, MD, MPH; Chief Editor: Mary C Mancini, MD, PhD, MMM  more...
 
Updated: Jun 10, 2016
 

Laboratory Studies

The diagnosis of vascular tumors and malformations is usually made solely on the basis of the history and physical examination. No laboratory studies are specifically useful in this setting.

Next

Imaging Studies

Magnetic resonance imaging (MRI) provides precise localization of the lesion. It is performed to detect the presence or absence of associated nervous system abnormalities. Furthermore, because vascular tumors have a distinct appearance on MRI, it is used in the diagnosis of atypical lesions.

Ultrasonography with color flow is cost-effective; however, it is operator-dependent and does not accurately depict the relation of the lesion to other anatomic structures.

Intracranial vascular anomalies are present in more than two thirds of patients with a periorbital lymphatic malformation and potentially require treatment.[35] Imaging of patients with orbital lymphatic malformation should include the brain as well as the orbit.

Prenatal diagnosis of an intracranial, rapidly involuting congenital hemangioma by means of prenatal imaging has been described.[36]

Previous
Next

Diagnostic Procedures

Biopsy is performed if malignancy is suspected.

Previous
 
 
Contributor Information and Disclosures
Author

Robert A Schwartz, MD, MPH Professor and Head of Dermatology, Professor of Pathology, Pediatrics, Medicine, and Preventive Medicine and Community Health, Rutgers New Jersey Medical School; Visiting Professor, Rutgers University School of Public Affairs and Administration

Robert A Schwartz, MD, MPH is a member of the following medical societies: Alpha Omega Alpha, New York Academy of Medicine, American Academy of Dermatology, American College of Physicians, Sigma Xi

Disclosure: Nothing to disclose.

Coauthor(s)

Tzongier J Wei, MD, MPH Assistant Professor of Pediatrics, Rutgers New Jersey Medical School; Chief and Director, Neonatal Intensive Care Unit, Department of Pediatrics, University Hospital

Tzongier J Wei, MD, MPH is a member of the following medical societies: American Academy of Pediatrics

Disclosure: Nothing to disclose.

Herbert Dardik, MD, FACS Clinical Professor of Surgery, Icahn School of Medicine at Mount Sinai; Chief, Department of Surgery, Chief, Vascular Surgical Service, Englewood Hospital and Medical Center

Disclosure: Nothing to disclose.

Richie L Lin, MD Staff Physician, Department of Dermatology, Rutgers New Jersey Medical School

Disclosure: Nothing to disclose.

Specialty Editor Board

Mary L Windle, PharmD Adjunct Associate Professor, University of Nebraska Medical Center College of Pharmacy; Editor-in-Chief, Medscape Drug Reference

Disclosure: Nothing to disclose.

Andre Hebra, MD Chief, Division of Pediatric Surgery, Professor of Surgery and Pediatrics, Medical University of South Carolina College of Medicine; Surgeon-in-Chief, Medical University of South Carolina Children's Hospital

Andre Hebra, MD is a member of the following medical societies: Alpha Omega Alpha, Florida Medical Association, Society of American Gastrointestinal and Endoscopic Surgeons, Children's Oncology Group, International Pediatric Endosurgery Group, American Academy of Pediatrics, American College of Surgeons, American Medical Association, American Pediatric Surgical Association, Society of Laparoendoscopic Surgeons, South Carolina Medical Association, Southeastern Surgical Congress, Southern Medical Association

Disclosure: Nothing to disclose.

Chief Editor

Mary C Mancini, MD, PhD, MMM Professor and Chief of Cardiothoracic Surgery, Department of Surgery, Louisiana State University School of Medicine in Shreveport

Mary C Mancini, MD, PhD, MMM is a member of the following medical societies: American Association for Thoracic Surgery, American College of Surgeons, American Surgical Association, Society of Thoracic Surgeons, Phi Beta Kappa

Disclosure: Nothing to disclose.

Acknowledgements

Jeff L Myers, MD, PhD Chief, Pediatric and Congenital Cardiac Surgery, Department of Surgery, Massachusetts General Hospital; Associate Professor of Surgery, Harvard Medical School

Jeff L Myers, MD, PhD is a member of the following medical societies: American College of Surgeons, American Heart Association, and International Society for Heart and Lung Transplantation

Disclosure: Nothing to disclose.

The authors and editors of Medscape Reference gratefully acknowledge the contributions of previous author Neal Ammar, MD, to the development and writing of this article.

References
  1. Mulliken JB, Glowacki J. Hemangiomas and vascular malformations in infants and children: a classification based on endothelial characteristics. Plast Reconstr Surg. 1982 Mar. 69(3):412-22. [Medline].

  2. Meine JG, Schwartz RA, Janniger CK. Klippel-Trenaunay-Weber syndrome. Cutis. 1997 Sep. 60(3):127-32. [Medline].

  3. Kihiczak NI, Schwartz RA, Jozwiak S, et al. Sturge-Weber syndrome. Cutis. 2000 Mar. 65(3):133-6. [Medline].

  4. Sung HM, Chung HY, Lee SJ, Lee JM, Huh S, Lee JW, et al. Clinical Experience of the Klippel-Trenaunay Syndrome. Arch Plast Surg. 2015 Sep. 42 (5):552-8. [Medline].

  5. Metry DW, Haggstrom AN, Drolet BA, et al. A prospective study of PHACE syndrome in infantile hemangiomas: Demographic features, clinical findings, and complications. Am J Med Genet A. 2006 Mar 30. [Medline].

  6. Bielenberg DR, Bucana CD, Sanchez R, et al. Progressive growth of infantile cutaneous hemangiomas is directly correlated with hyperplasia and angiogenesis of adjacent epidermis and inversely correlated with expression of the endogenous angiogenesis inhibitor, IFN-beta. Int J Oncol. 1999 Mar. 14(3):401-8. [Medline].

  7. Beck L Jr, D'Amore PA. Vascular development: cellular and molecular regulation. FASEB J. 1997 Apr. 11(5):365-73. [Medline].

  8. Razon MJ, Kraling BM, Mulliken JB, Bischoff J. Increased apoptosis coincides with onset of involution in infantile hemangioma. Microcirculation. 1998. 5(2-3):189-95. [Medline].

  9. Bischoff J. Progenitor cells in infantile hemangioma. J Craniofac Surg. 2009 Mar. 20 Suppl 1:695-7. [Medline].

  10. Rydh M, Malm M, Jernbeck J, Dalsgaard CJ. Ectatic blood vessels in port-wine stains lack innervation: possible role in pathogenesis. Plast Reconstr Surg. 1991 Mar. 87(3):419-22. [Medline].

  11. Itakura E, Yamamoto H, Oda Y, Furue M, Tsuneyoshi M. VEGF-C and VEGFR-3 in a series of lymphangiomas: Is superficial lymphangioma a true lymphangioma?. Virchows Arch. 2009 Mar. 454(3):317-25. [Medline].

  12. Wang L, Gao T, Wang G. Verrucous hemangioma: A clinicopathological and immunohistochemical analysis of 74 cases. J Cutan Pathol. 2014 Sep 26. [Medline].

  13. Blei F, Walter J, Orlow SJ, Marchuk DA. Familial segregation of hemangiomas and vascular malformations as an autosomal dominant trait. Arch Dermatol. 1998 Jun. 134(6):718-22. [Medline].

  14. Reimer A, Fliesser M, Hoeger PH. Anatomical patterns of infantile hemangioma (IH) of the extremities (IHE). J Am Acad Dermatol. 2016 Apr 21. [Medline].

  15. Hershkovitz D, Bergman R, Sprecher E. A novel mutation in RASA1 causes capillary malformation and limb enlargement. Arch Dermatol Res. 2008 Aug. 300(7):385-8. [Medline].

  16. Chang MB, Newman CC, Davis MD, Lehman JS. Acquired lymphangiectasia (lymphangioma circumscriptum) of the vulva: Clinicopathologic study of 11 patients from a single institution and 67 from the literature. Int J Dermatol. 2016 Mar 9. [Medline].

  17. Holmdahl K. Cutaneous hemangiomas in premature and mature infants. Acta Paediatrica Scandinavica. 1955. 44:370.

  18. Amir J, Metzker A, Krikler R, Reisner SH. Strawberry hemangioma in preterm infants. Pediatr Dermatol. 1986 Sep. 3(4):331-2. [Medline].

  19. Jacobs AH, Walton RG. The incidence of birthmarks in the neonate. Pediatrics. 1976 Aug. 58(2):218-22. [Medline].

  20. Filston HC. Hemangiomas, cystic hygromas, and teratomas of the head and neck. Semin Pediatr Surg. 1994 Aug. 3(3):147-59. [Medline].

  21. Orten SS, Waner M, Flock S, et al. Port-wine stains. An assessment of 5 years of treatment. Arch Otolaryngol Head Neck Surg. 1996 Nov. 122(11):1174-9. [Medline].

  22. Finn MC, Glowacki J, Mulliken JB. Congenital vascular lesions: clinical application of a new classification. J Pediatr Surg. 1983 Dec. 18(6):894-900. [Medline].

  23. Hidano A, Nakajima S. Earliest features of the strawberry mark in the newborn. Br J Dermatol. 1972 Aug. 87(2):138-44. [Medline].

  24. Santiago MB, Lima I, Feitosa AC, Braz Ade S, Miranda LG. Pseudoclubbing: is it different from clubbing?. Semin Arthritis Rheum. 2009 Jun. 38(6):452-7. [Medline].

  25. Berg JN, Walter JW, Thisanagayam U, et al. Evidence for loss of heterozygosity of 5q in sporadic haemangiomas: are somatic mutations involved in haemangioma formation?. J Clin Pathol. 2001 Mar. 54(3):249-52. [Medline]. [Full Text].

  26. Walter JW, Blei F, Anderson JL, et al. Genetic mapping of a novel familial form of infantile hemangioma. Am J Med Genet. 1999 Jan 1. 82(1):77-83. [Medline].

  27. Pugalagiri P, Muller S, Cox DP, Kessler HP, Wright JM, Cheng YS. Lymphangioma-like Kaposi sarcoma of the oral mucosa. Oral Surg Oral Med Oral Pathol Oral Radiol. 2013 Jul. 116(1):84-90. [Medline].

  28. Massa AF, Menezes N, Baptista A, Moreira AI, Ferreira EO. Cutaneous Lymphangioma circumscriptum - dermoscopic features. An Bras Dermatol. 2015 Mar-Apr. 90 (2):262-4. [Medline].

  29. Oiso N, Kimura M, Kawara S, Kawada A. Clinical, dermoscopic, and histopathologic features in a case of infantile hemangioma without proliferation. Pediatr Dermatol. 2011 Jan-Feb. 28(1):66-8. [Medline].

  30. Maguiness SM, Hoffman WY, McCalmont TH, Frieden IJ. Early white discoloration of infantile hemangioma: a sign of impending ulceration. Arch Dermatol. 2010 Nov. 146(11):1235-9. [Medline].

  31. Redondo P, Aguado L, Martínez-Cuesta A. Diagnosis and management of extensive vascular malformations of the lower limb: part I. Clinical diagnosis. J Am Acad Dermatol. 2011 Nov. 65(5):893-906; quiz 907-8. [Medline].

  32. Redondo P, Aguado L, Martínez-Cuesta A. Diagnosis and management of extensive vascular malformations of the lower limb: part II. Systemic repercussions [corrected], diagnosis, and treatment. J Am Acad Dermatol. 2011 Nov. 65(5):909-23; quiz 924. [Medline].

  33. Yilmaz T, Cikla U, Kirst A, Baskaya MK. Glioblastoma multiforme in Klippel-Trenaunay-Weber syndrome: a case report. J Med Case Rep. 2015 Apr 17. 9:83. [Medline].

  34. Arica DA, Arica IE, Yayli S, Cobanoglu U, Akay BN, Anadolu R, et al. Spitz nevus arising upon a congenital glomuvenous malformation. Pediatr Dermatol. 2012 Feb 3. [Medline].

  35. Bisdorff A, Mulliken JB, Carrico J, Robertson RL, Burrows PE. Intracranial vascular anomalies in patients with periorbital lymphatic and lymphaticovenous malformations. AJNR Am J Neuroradiol. 2007 Feb. 28(2):335-41. [Medline].

  36. Fadell MF 2nd, Jones BV, Adams DM. Prenatal diagnosis and postnatal follow-up of rapidly involuting congenital hemangioma (RICH). Pediatr Radiol. 2011 Feb 22. [Medline].

  37. Greinwald JH Jr, Burke DK, Sato Y, et al. Treatment of lymphangiomas in children: an update of Picibanil (OK-432) sclerotherapy. Otolaryngol Head Neck Surg. 1999 Oct. 121(4):381-7. [Medline].

  38. Limaye N, Boon LM, Vikkula M. From germline towards somatic mutations in the pathophysiology of vascular anomalies. Hum Mol Genet. 2009 Apr 15. 18:R65-74. [Medline].

  39. Brown SH Jr, Neerhout RC, Fonkalsrud EW. Prednisone therapy in the management of large hemangiomas in infants and children. Surgery. 1972 Feb. 71(2):168-73. [Medline].

  40. Schwartz RA, Sidor MI, Musumeci ML, Lin RL, Micali G. Infantile haemangiomas: a challenge in paediatric dermatology. J Eur Acad Dermatol Venereol. 2010 Jun. 24(6):631-8. [Medline].

  41. Jadhav VM, Tolat SN. Dramatic response of propranolol in hemangioma: report of two cases. Indian J Dermatol Venereol Leprol. 2010 Nov-Dec. 76(6):691-4. [Medline].

  42. Chik KK, Luk CK, Chan HB, Tan HY. Use of propranolol in infantile haemangioma among Chinese children. Hong Kong Med J. 2010 Oct. 16(5):341-6. [Medline].

  43. Khunger N, Pahwa M. Dramatic response of a large hemifacial infantile hemangioma associated with PHACE syndrome to topical timolol lotion. Br J Dermatol. 2010 Dec 15. [Medline].

  44. Frommelt P, Juern A, Siegel D, Holland K, Seefeldt M, Yu J, et al. Adverse Events in Young and Preterm Infants Receiving Topical Timolol for Infantile Hemangioma. Pediatr Dermatol. 2016 May 31. [Medline].

  45. Ezekowitz RA, Mulliken JB, Folkman J. Interferon alfa-2a therapy for life-threatening hemangiomas of infancy. N Engl J Med. 1992 May 28. 326(22):1456-63. [Medline].

  46. DI Maio L, Baldi A, Dimaio V, Barzi A. Use of flashlamp-pumped pulsed dye laser in the treatment of superficial vascular malformations and ulcerated hemangiomas. In Vivo. 2011 Jan-Feb. 25(1):117-23. [Medline].

  47. Morelli JG, Tan OT, Yohn JJ, Weston WL. Treatment of ulcerated hemangiomas infancy. Arch Pediatr Adolesc Med. 1994 Oct. 148(10):1104-5. [Medline].

  48. Steiner F, FitzJohn T, Tan ST. Ethanol sclerotherapy for venous malformation. ANZ J Surg. 2014 Sep 2. [Medline].

  49. Pires AM, Reinehr C, Boff F, Nazar FL. Intralesional bleomycin sclerotherapy of lymphangioma: partial response to treatment. Dermatol Surg. 2015 Jan. 41 (1):175-7. [Medline].

  50. Park CO, Lee MJ, Chung KY. Treatment of unusual vascular lesions: usefulness of sclerotherapy in lymphangioma circumscriptum and acquired digital arteriovenous malformation. Dermatol Surg. 2005 Nov. 31(11 Pt 1):1451-3. [Medline].

  51. Gottschling S, Schneider G, Meyer S, et al. Two infants with life-threatening diffuse neonatal hemangiomatosis treated with cyclophosphamide. Pediatr Blood Cancer. 2006 Feb. 46(2):239-42. [Medline].

  52. Kennedy TL, Whitaker M, Pellitteri P, Wood WE. Cystic hygroma/lymphangioma: a rational approach to management. Laryngoscope. 2001 Nov. 111(11 Pt 1):1929-37. [Medline].

  53. Mulliken JB, Rogers GF, Marler JJ. Circular excision of hemangioma and purse-string closure: the smallest possible scar. Plast Reconstr Surg. 2002 Apr 15. 109(5):1544-54; discussion 1555. [Medline].

  54. Riechelmann H, Muehlfay G, Keck T, et al. Total, subtotal, and partial surgical removal of cervicofacial lymphangiomas. Arch Otolaryngol Head Neck Surg. 1999 Jun. 125(6):643-8. [Medline].

  55. Shumaker PR, Dela Rosa KM, Krakowski A. Treatment of Lymphangioma Circumscriptum Using Fractional Carbon Dioxide Laser Ablation. Pediatr Dermatol. 2013 Jun 12. [Medline].

 
Previous
Next
 
Fully developed vascular tumor on trunk of infant.
Large vascular tumor encompassing upper extremity and portions of trunk, clinically diagnosed.
Lower extremity port-wine stain in patient with Klippel-Trenaunay-Weber syndrome.
 
 
 
All material on this website is protected by copyright, Copyright © 1994-2016 by WebMD LLC. This website also contains material copyrighted by 3rd parties.